Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Rous

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
The Lancet. Oncology|February 19, 2026
Influence of stage at cancer diagnosis on NHS hospital care costs in England: a national, retrospective, population-based cohort study using individual patient-level dataClare Pearson, David A Jones, Gavin Baily, et al.
Neuroendocrinology|March 20, 2023
Second Primary Malignancies in Patients with a Neuroendocrine Neoplasm in EnglandBeth Russell, Benjamin E White, Brian Rous, et al.
The Journal of Pathology|December 13, 2019
p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsiesNaveena Singh, Anna M Piskorz, Tjalling Bosse, et al.
International Journal of Cancer|December 21, 2022
Incidence and survival of soft tissue sarcoma in England between 2013 and 2017, an analysis from the National Cancer Registration and Analysis ServiceAndrew Bacon, Kwok Wong, Malee S Fernando, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 15, 2021
Immunohistochemistry and Next-generation Sequencing Are Complementary Tests in Identifying PTEN Abnormality in Endometrial Carcinoma BiopsiesLinyuan Wang, Anna Piskorz, Tjalling Bosse, et al.
Cancers|March 29, 2023
Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012-2018: A Retrospective, Population-Based StudyBenjamin E White, Beth Russell, Sebastiaan Remmers, et al.
The Lancet Regional Health. Europe|September 30, 2022
Incidence and survival of neuroendocrine neoplasia in England 1995-2018: A retrospective, population-based studyBenjamin E White, Brian Rous, Kandiah Chandrakumaran, et al.
Cancer Epidemiology|January 23, 2026
The International Classification of Diseases for Oncology, 4th Edition (ICD-O-4): An overviewAriana Znaor, Brian Rous, Gabrielle Goldman Levy, et al.
The British Journal of Dermatology|December 4, 2021
Validation of four cutaneous squamous cell carcinoma staging systems using nationwide dataZoe Claire Venables, Selin Tokez, Loes M Hollestein, et al.
JAMA Dermatology|November 29, 2018
Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in EnglandZoë C Venables, Philippe Autier, Tamar Nijsten, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
The Lancet. Oncology|February 19, 2026
Influence of stage at cancer diagnosis on NHS hospital care costs in England: a national, retrospective, population-based cohort study using individual patient-level dataClare Pearson, David A Jones, Gavin Baily, et al.
Neuroendocrinology|March 20, 2023
Second Primary Malignancies in Patients with a Neuroendocrine Neoplasm in EnglandBeth Russell, Benjamin E White, Brian Rous, et al.
The Journal of Pathology|December 13, 2019
p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsiesNaveena Singh, Anna M Piskorz, Tjalling Bosse, et al.
International Journal of Cancer|December 21, 2022
Incidence and survival of soft tissue sarcoma in England between 2013 and 2017, an analysis from the National Cancer Registration and Analysis ServiceAndrew Bacon, Kwok Wong, Malee S Fernando, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 15, 2021
Immunohistochemistry and Next-generation Sequencing Are Complementary Tests in Identifying PTEN Abnormality in Endometrial Carcinoma BiopsiesLinyuan Wang, Anna Piskorz, Tjalling Bosse, et al.
Cancers|March 29, 2023
Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012-2018: A Retrospective, Population-Based StudyBenjamin E White, Beth Russell, Sebastiaan Remmers, et al.
The Lancet Regional Health. Europe|September 30, 2022
Incidence and survival of neuroendocrine neoplasia in England 1995-2018: A retrospective, population-based studyBenjamin E White, Brian Rous, Kandiah Chandrakumaran, et al.
Cancer Epidemiology|January 23, 2026
The International Classification of Diseases for Oncology, 4th Edition (ICD-O-4): An overviewAriana Znaor, Brian Rous, Gabrielle Goldman Levy, et al.
The British Journal of Dermatology|December 4, 2021
Validation of four cutaneous squamous cell carcinoma staging systems using nationwide dataZoe Claire Venables, Selin Tokez, Loes M Hollestein, et al.
JAMA Dermatology|November 29, 2018
Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in EnglandZoë C Venables, Philippe Autier, Tamar Nijsten, et al.
Pageof 5